Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 16 2014
Print RSS Feed

Contract Pharma Experts


Mico Holguin, Jr., Pharma Partner Executive, Baxter BioPharma Solutions / Baxter Healthcare Corp.
Mico Holguin graduated from the University of Notre Dame before entering the U.S. Army as an Infantry Officer. After completing several assignments at Fort Bragg, NC, Fort Lewis, WA and Fort Knox, KY, Mico resigned from the Army and held sales positions in Colgate-Palmolive and Abbott Laboratories.

In 1993, Mico transitioned to business development for Abbott Laboratories while representing API and eventually Fill/Finish contract management services. Mico also spent seven years with Cardinal/Catalent in BD also representing Fill/Finish services before recently taking a Pharma Partner Executive position with Baxter Biopharma Solutions.

Mico completed his MBA in 1999 and retired from the U.S. Army after 27 years of Active/Reservist service which includes four years as a member of Special Forces. He resides in Illinois and is a current member of PDA.
Dr. Makarand S. Jawadekar, Consultant, Pfizer Global R&D (ret'd.)
Dr. Mak Jawadekar was formerly a director, Portfolio Management & Analytics, as well as a vice president of CRG Asia Pacific Group at Pfizer, Inc. in CT. In the recent past, he was responsible for Benchmarking R&D Portfolio for Pfizer, working with Benchmarking Forums, and Drug Delivery Technology Assessment functions. He has extensive experience in creating and cultivating external partnerships for Outsourcing CMC as well as DDS alliances for Pfizer Global R&D.

He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota. He spent more than 28 years with Pfizer, including R&D areas, heading solids R&D, drug product formulation/dosage form/drug delivery R&D, clinical trials supply manufacturing and packaging, and scale-up and technology transfer, as well as pharmacy (CMC) areas. He managed several functions/groups within pharmaceutical R&D for many years.

In the recent past, he had been also been engaged in coordinating outsourcing R&D activities with external partners/service providers. He was presented with the "M.L. Khorana Memorial Lecture of the Year Award" at the Indian Pharmaceutical Congress held in New Delhi, India, in December 2001 for his Presentation on 'Advances in Drug Development and Delivery Systems with a Focus on Protection of Intellectual Property Rights.' He has presented at many professional meetings and has participated in various panel discussions and roundtables.
Bobby A. Kanuga, Executive Director of External Manufacturing Operations, Merck & Co., Inc.
Bob Kanuga has over 20 years' of experience in manufacturing and business development within the pharmaceutical industry He is currently Executive Director of External Manufacturing at Merck & Co., Inc. responsible for the global supply of outsourced chemical intermediates, active pharmaceutical ingredients, sterile and non-sterile drug products, drug delivery systems and packaging services. Prior to this role, he held many commercial and operations related positions within the company's Manufacturing Division, including Vaccine & Sterile Manufacturing, Global Procurement, and Business Affairs. He received his BS and MBA from Lehigh University.
Richard Korsmeyer, Head of Licensing, Worldwide Pharmaceutical Sciences, Pfizer Global R&D
Richard Korsmeyer has been with Pfizer since 1986 in various roles as a scientist and manager. He is currently a Senior Research Fellow and the Head of Business Development for Pharmaceutical Sciences, where leads a cross-divisional team comprising representatives from Pharmaceutical Sciences (R&D) and Pfizer Global Supply (Commercial Manufacturing), responsible for supporting all Business Development activities including in-licensing, out-licensing, mergers, acquisitions, divestitures, and income-generating initiatives. This team manages all project aspects related to CMC for opportunities from Due Diligence through negotiations and project on-boarding.

As a member of the Technology and Strategic Sourcing organization, he also supports research and technology collaborations and sourcing strategy for R&D stage programs. He maintains a special interest in drug delivery technology.

Richard obtained his Bachelor's degree in Chemistry from Vanderbilt University and subsequently graduated from Purdue University with a Master's and a PhD in Chemical Engineering. Before coming to Pfizer, he worked as a chemist and engineer. He has published in the areas of organic chemistry, polymer science, diffusion, and drug delivery and holds a number of patents. He is a member of American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists, The Controlled Release Society, and the College of Fellows of the American Institute of Medical and Biological Engineering.

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On